Cancer ameliorates cardiac dysfunction and suppresses fibrosis in a mouse model for Duchenne muscular dystrophy

Abstract The interplay between heart failure and cancer represents a double-edged sword. Whereas cardiac remodeling promotes cancer progression, tumor growth suppresses cardiac hypertrophy and reduces fibrosis deposition. Whether these two opposing interactions are connected awaits to be determined. In addition, it is not known whether cancer affects solely the heart, or if other organs are affected as well. To explore the dual interaction between heart failure and cancer, we studied the human genetic disease Duchenne Muscular Dystrophy (DMD) using the MDX mouse model. We analyzed fibrosis and cardiac function as well as molecular parameters by multiple methods in the heart, diaphragm, lungs, skeletal muscles, and tumors derived from MDX and control mice. Surprisingly, cardiac dysfunction in MDX mice failed to promote murine cancer cell growth. In contrast, tumor-bearing MDX mice displayed reduced fibrosis in the heart , skeletal and diaphragm muscles, resulting in improved cardiac function. The latter is at least partially mediated via M2 macrophage recruitment to the heart and diaphragm muscles. Remarkably, an analysis of of cytokines in the blood of tumor-bearing and non-tumor-bearing MDX mice initially revealed several potential factors. These factors hold promise in significantly reducing fibrosis within our model. Administering these factors simultaneously to MDX mice led to decreased fibrosis in the heart, diaphragm, and skeletal muscles, along with an improvement in cardiac function. Collectively, our data support the notion that the effect of heart failure on tumor promotion is independent of the improved cardiac function in tumor-bearing mice. Reduced fibrosis in tumor-bearing MDX mice stems from the suppression of new fibrosis synthesis and the removal of existing fibrosis. These findings offer potential therapeutic strategies for DMD patients, fibrotic diseases, and cardiac dysfunction.Tumor growth suppresses fibrosisGraphical representation

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2024-10-01
DOI
https://doi.org/10.1093/eurheartj/ehae666.3814
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cancer ameliorates cardiac dysfunction and suppresses fibrosis in a mouse model for Duchenne muscular dystrophy

Lama Awwad, Laris Achlaug, Ami Aronheim, Irina Langier-Goncalves et al.
European Heart Journal
Muscle Physiology and Disorders
article

Cancer ameliorates cardiac dysfunction and suppresses fibrosis in a mouse model for Duchenne muscular dystrophy

Lama Awwad, Laris Achlaug, Ami Aronheim, Irina Langier-Goncalves, Tsvi Goldenberg
article en

Abstract

Abstract The interplay between heart failure and cancer represents a double-edged sword. Whereas cardiac remodeling promotes cancer progression, tumor growth suppresses cardiac hypertrophy and reduces fibrosis deposition. Whether these two opposing interactions are connected awaits to be determined. In addition, it is not known whether cancer affects solely the heart, or if other organs are affected as well. To explore the dual interaction between heart failure and cancer, we studied the human genetic disease Duchenne Muscular Dystrophy (DMD) using the MDX mouse model. We analyzed fibrosis and cardiac function as well as molecular parameters by multiple methods in the heart, diaphragm, lungs, skeletal muscles, and tumors derived from MDX and control mice. Surprisingly, cardiac dysfunction in MDX mice failed to promote murine cancer cell growth. In contrast, tumor-bearing MDX mice displayed reduced fibrosis in the heart , skeletal and diaphragm muscles, resulting in improved cardiac function. The latter is at least partially mediated via M2 macrophage recruitment to the heart and diaphragm muscles. Remarkably, an analysis of of cytokines in the blood of tumor-bearing and non-tumor-bearing MDX mice initially revealed several potential factors. These factors hold promise in significantly reducing fibrosis within our model. Administering these factors simultaneously to MDX mice led to decreased fibrosis in the heart, diaphragm, and skeletal muscles, along with an improvement in cardiac function. Collectively, our data support the notion that the effect of heart failure on tumor promotion is independent of the improved cardiac function in tumor-bearing mice. Reduced fibrosis in tumor-bearing MDX mice stems from the suppression of new fibrosis synthesis and the removal of existing fibrosis. These findings offer potential therapeutic strategies for DMD patients, fibrotic diseases, and cardiac dysfunction.Tumor growth suppresses fibrosisGraphical representation

European Heart JournalVol. 45(Supplement_1)
Technion – Israel Institute of Technology (IL)
Openalex Percentile: Top 83%
Muscle Physiology and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.